Innovative Research Focus Gateway Institute for Brain Research specializes in pioneering clinical trials targeting Parkinson's disease, offering opportunities to collaborate or provide specialized solutions in neuroscience research and clinical trial support.
Growing Revenue Potential With an annual revenue estimated between 10 and 25 million dollars, the company presents a substantial market opportunity for advanced research technology, lab equipment, and data management solutions tailored to neuroscience research startups.
Technology Integration Utilizing a modern tech stack including Wix, Sentry, and Envoy, Gateway Institute values innovative digital solutions, indicating openness to partnerships in cybersecurity, website optimization, and cloud services.
Research Expansion Opportunities The active clinical trials in microbiota intervention and intranasal therapies suggest expansion possibilities and a need for specialized research tools, data analytics, and compliance solutions to support ongoing and future trials.
Targeted Neuroresearch Market Positioned within a competitive landscape with institutes focused on neuroscience, Gateway Institute offers tailored opportunities for companies providing neuroimaging, biotechnological, and pharmaceutical research products and services to enhance their outreach.
$50M$100M
$10M$25M
$50M$100MGateway Institute for Brain Research uses 8 technology products and services including Wix, Module Federation, Sentry, and more. Explore Gateway Institute for Brain Research's tech stack below.
| Gateway Institute for Brain Research Email Formats | Percentage |
| FLast@gifbr.com | 47% |
| First.Last@gifbr.com | 3% |
| First@gifbr.com | 3% |
| FLast@gifbr.com | 47% |
Research ServicesFlorida, United States11-50 Employees
Two exciting clinical trials that address Parkinson's disease from the Gateway Institute for Brain Research. Microbiota Intervention to Change the Response of Parkinson's Disease (MICRO-PD) https://clinicaltrials.gov/ct2/show/NCT03575195 Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease (NOSE-PD) https://clinicaltrials.gov/ct2/show/NCT05266417
Company Overview
Funding & FinancialsGateway Institute for Brain Research's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsGateway Institute for Brain Research's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com